Variable | Total n (%) N = 68 | March-to-August n (%) | P-value | |
---|---|---|---|---|
2019 N = 42 | 2020 N = 26 | |||
Gender | ||||
 Male | 32 (47.1) | 17 (40.5) | 15 (57.7) | 0.258 |
 Female | 36 (52.9) | 25 (59.5) | 11 (42.3) | |
Age (years) (mean ± SD) | 40.6 ± 16.8 | 38.7 ± 16.2 | 43.6 ± 17.6 | 0.246 |
Arrival mode | ||||
 Ambulance | 55 (80.9) | 37 (88.1) | 18 (69.2) | 0.108 |
 Other | 13 (19.1) | 5 (11.9) | 8 (30.8) |  |
Nature of overdosea | ||||
 Intentional | 32 (47.8) | 22 (53.7) | 10 (38.5) | 0.336 |
 Unintentional | 35 (52.2) | 19 (46.3) | 16 (61.5) |  |
Opioids used in overdoseb | ||||
 Pharmaceutical | 49 (72.1) | 32 (76.2) | 17 (65.4) | 0.492 |
 Non-pharmaceutical | 19 (27.9) | 10 (23.8) | 9 (34.6) |  |
Drugs used in overdose | ||||
 Opioids only | 23 (33.8) | 18 (42.9) | 5 (19.2) | 0.082 |
 Opioids and non | 45 (66.2) | 24 (57.1) | 21 (80.8) |  |
opioids | ||||
Number of drugs consumed in overdose | ||||
 1–3 | 49 (72.1) | 34 (81.0) | 15 (57.7) | 0.072 |
 4–7 | 19 (27.9) | 8 (19.0) | 11 (42.3) |  |
Inpatient admission | ||||
 Yes | 18 (26.5) | 11 (26.2) | 7 (26.9) | 1.000 |
 No | 50 (73.5) | 31 (73.8) | 19 (73.1) |  |
ED and/or ambulance naloxone provided | ||||
 Yes | 28 (41.2) | 14 (33.3) | 14 (53.8) | 0.157 |
 No | 40 (58.8) | 28 (66.7) | 12 (46.2) |  |